Furthermore, resistin has been shown to confer resistance to doxorubicin-induced apoptosis in human breast cancer cells [12], enhance cisplatin-induced cytotoxicity in lung adenocarcinoma cells [13], and contribute to 5-fluorouracil chemoresistance in human colorectal cancer cells [14]. This evidence concerns the gene RETN and breast carcinoma.